Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950005-04-000342
Filing Date
2004-04-06
Accepted
2004-04-06 15:10:06
Documents
15
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT p18248_10k.txt 10-K 273644
3 CERTIFICATE OF AMENDMENT p18248_ex3-2.txt EX-3.2 3513
4 EMPLOYMENT AGREEMENT p18248_ex10-6.txt EX-10.6 35311
5 COMMON STOCK PURCHASE AGREEMENT p18248_ex10-9.txt EX-10.9 127446
6 REGISTRATION RIGHTS AGEEMENT p18248_ex10-10.txt EX-10.10 46482
7 WARRANT AGREEMENT p18248_ex10-11.txt EX-10.11 34611
8 OFFER LETTER RICHARD WILLIAMS p18248_ex10-14.txt EX-10.14 5424
9 STOCK OPTION AGREEMENT p18248_ex10-15.txt EX-10.15 31290
10 INDEMNIFICATION AGREEMENT p18248_ex10-16.txt EX-10.16 35807
11 CONSENT OF INDEPENDENT ACCOUNTANTS p18248_ex23-1.txt EX-23.1 651
12 CONSENT OF ERNST & YOUNG LLP p18248_ex23-2.txt EX-23.2 1019
13 CERTIFICATIONS p18248_ex31-1.txt EX-31.1 3522
14 CERTIFICATIONS p18248_ex31-2.txt EX-31.2 3608
15 CERTIFICATION p18248_ex32-1.txt EX-32.1 1319
16 CERTIFICATION p18248_ex32-2.txt EX-32.2 1396
  Complete submission text file 0000950005-04-000342.txt   608395
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 04720218
SIC: 2834 Pharmaceutical Preparations